Skip to content
My WebMD Sign In, Sign Up

Lung Disease & Respiratory Health Center

Font Size
A
A
A

FDA Rethinks Spiriva Stroke Warning

Spiriva Inhaler Not Linked to Stroke, New Study Suggests
By
WebMD Health News
Reviewed by Louise Chang, MD

sprivia_no_stroke_risk.jpg

Oct. 9, 2008 – The FDA is reconsidering its recent warning that the lung disease drug Spiriva might raise stroke risk.

The warning came after Spiriva maker Boehringer Ingelheim analyzed pooled data from 29 Spiriva studies. These studies suggested that for every 1,000 patients taking Spiriva, there were two extra cases of stroke.

Now there's new data from the four-year UPLIFT study of some 6,000 patients with chronic obstructive pulmonary disease (COPD). The patients -- average age 65 -- took Spiriva or placebo in addition to other types of respiratory drugs.

There were 82 strokes among the 2,987 patients taking Spiriva and 80 strokes among the 3,006 patients getting an inactive placebo. The difference is not statistically significant.

The FDA says it will take several months for it to finish it's review of the huge amount of data from the UPLIFT study. At that time, the federal agency says it will release all existing data on Spiriva and stroke risk.

Today on WebMD

Hot Tub Disease
Article
Lung Disease Health Check
HEALTH CHECK
 
Cigarette butts in ashtray
Article
Household Hazards For People With Copd
Article
 

Bronchitis Overview
SLIDESHOW
Copd Myth Fact Quiz
QUIZ
 
Living With Copd
VIDEO
Energy Boosting Foods
SLIDESHOW
 

cigarette butts snuffed out in ashtray
SLIDESHOW
Healthy Home Health Check
TOOL
 
Senior woman stretching
Article
Diagnosing Copd
VIDEO
 

WebMD Special Sections